Literature DB >> 27440719

Greener synthesis of indolizine analogues using water as a base and solvent: study for larvicidal activity against Anopheles arabiensis.

Chandrashekharappa Sandeep1, Katharigatta N Venugopala2, Raquel M Gleiser3, Abeen Chetram4, Basavaraj Padmashali5,6, Rashmi S Kulkarni7, Rashmi Venugopala8, Bharti Odhav4.   

Abstract

Greener synthesis of a series of novel indolizine analogues have been achieved by the cyclization of aromatic cycloimmonium ylides with electron-deficient alkynes in the presence of water as the base and solvent at 80 °C. Yield of the title compounds was good and reactions performed were eco-friendly. The structures of these newly synthesized compounds have been confirmed by spectroscopic techniques such as FTIR, NMR, LC-MS, and elemental analysis. Characterized title compounds were evaluated for larvicidal activity against Anopheles arabiensis by standard WHO larvicidal assay using Temefos as standard at 4 μg/mL. Title compounds 2e, 2f, and 2g emerged as promising larvicidal agents.
© 2016 John Wiley & Sons A/S.

Entities:  

Keywords:  characterization; indolizine analogues; larvicidal activity; synthesis

Mesh:

Substances:

Year:  2016        PMID: 27440719     DOI: 10.1111/cbdd.12823

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  8 in total

1.  1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study.

Authors:  Katharigatta N Venugopala; Pottathil Shinu; Christophe Tratrat; Pran Kishore Deb; Raquel M Gleiser; Sandeep Chandrashekharappa; Deepak Chopra; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Fawzi M Mahomoodally; Michelyne Haroun; Mahmoud Kandeel; Syed Mohammed Basheeruddin Asdaq; Viresh Mohanlall; Nizar A Al-Shar'i; Mohamed A Morsy
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

2.  Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

Authors:  Katharigatta Narayanaswamy Venugopala; Sandeep Chandrashekharappa; Melendhran Pillay; Hassan H Abdallah; Fawzi M Mahomoodally; Subhrajyoti Bhandary; Deepak Chopra; Mahesh Attimarad; Bandar E Aldhubiab; Anroop B Nair; Nagaraja Sreeharsha; Mohamed A Morsy; Shinu Pottathil; Rashmi Venugopala; Bharti Odhav; Koleka Mlisana
Journal:  PLoS One       Date:  2019-06-04       Impact factor: 3.240

3.  Design, synthesis, and structural elucidation of novel NmeNANAS inhibitors for the treatment of meningococcal infection.

Authors:  Osama I Alwassil; Sandeep Chandrashekharappa; Susanta K Nayak; Katharigatta N Venugopala
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

4.  Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.

Authors:  Katharigatta N Venugopala; Christophe Tratrat; Melendhran Pillay; Fawzi M Mahomoodally; Subhrajyoti Bhandary; Deepak Chopra; Mohamed A Morsy; Michelyne Haroun; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Sandeep Chandrashekharappa; Osama I Alwassil; Bharti Odhav
Journal:  Antibiotics (Basel)       Date:  2019-12-03

5.  Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation.

Authors:  Vijayakumar Uppar; Sandeep Chandrashekharappa; Chandan Shivamallu; Sushma P; Shiva Prasad Kollur; Joaquín Ortega-Castro; Juan Frau; Norma Flores-Holguín; Atiyaparveen I Basarikatti; Mallikarjun Chougala; Mrudula Mohan M; Govindappa Banuprakash; Katharigatta N Venugopala; Belakatte P Nandeshwarappa; Ravindra Veerapur; Abdulaziz A Al-Kheraif; Abdallah M Elgorban; Asad Syed; Kiran K Mudnakudu-Nagaraju; Basavaraj Padmashali; Daniel Glossman-Mitnik
Journal:  Molecules       Date:  2021-05-06       Impact factor: 4.411

6.  Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Pran Kishore Deb; Christophe Tratrat; Melendhran Pillay; Deepak Chopra; Nizar A Al-Shar'i; Wafa Hourani; Lina A Dahabiyeh; Pobitra Borah; Rahul D Nagdeve; Susanta K Nayak; Basavaraj Padmashali; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Michelyne Haroun; Sheena Shashikanth; Viresh Mohanlall; Raghuprasad Mailavaram
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Christophe Tratrat; Pran Kishore Deb; Rahul D Nagdeve; Susanta K Nayak; Mohamed A Morsy; Pobitra Borah; Fawzi M Mahomoodally; Raghu Prasad Mailavaram; Mahesh Attimarad; Bandar E Aldhubiab; Nagaraja Sreeharsha; Anroop B Nair; Osama I Alwassil; Michelyne Haroun; Viresh Mohanlall; Pottathil Shinu; Rashmi Venugopala; Mahmoud Kandeel; Belakatte P Nandeshwarappa; Yasmine F Ibrahim
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

8.  Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target Investigation.

Authors:  Katharigatta N Venugopala; Pushpalatha Ramachandra; Christophe Tratrat; Raquel M Gleiser; Subhrajyoti Bhandary; Deepak Chopra; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Pran Kishore Deb; Sandeep Chandrashekharappa; Hany Ezzat Khalil; Osama I Alwassil; Sara Nidal Abed; Yazan A Bataineh; Ramachandra Palenge; Michelyne Haroun; Shinu Pottathil; Meravanige B Girish; Sabah H Akrawi; Viresh Mohanlall
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.